Marshall Z Schwartz

Author PubWeight™ 14.55‹?›

Top papers

Rank Title Journal Year PubWeight™‹?›
1 Hepatocyte growth factor treatment ameliorates diarrhea and bowel inflammation in a rat model of inflammatory bowel disease. J Pediatr Surg 2004 0.99
2 Modulation of the inflammatory response and apoptosis using epidermal growth factor and hepatocyte growth factor in a liver injury model: a potential approach to the management and treatment of cholestatic liver disease. J Pediatr Surg 2008 0.90
3 Vacuum-assisted closure in the treatment of extensive lymphangiomas in children. J Pediatr Surg 2012 0.87
4 Early experience with single-incision thoracoscopic surgery in the pediatric population. J Laparoendosc Adv Surg Tech A 2010 0.86
5 Leptin: a new growth factor for the small intestine. J Pediatr Surg 2002 0.84
6 IL-11 pretreatment reduces cell death after intestinal ischemia-reperfusion. J Surg Res 2002 0.83
7 Hepatocyte growth factor pretreatment reduces apoptosis and mucosal damage after intestinal ischemia-reperfusion. J Pediatr Surg 2002 0.81
8 Intralobar pulmonary sequestration: an uncommon case with triple arterial supply and systemic venous drainage. Pediatr Surg Int 2012 0.80
9 Single-incision thoracoscopic surgery in children: equivalent results with fewer scars when compared with traditional multiple-incision thoracoscopy. J Laparoendosc Adv Surg Tech A 2011 0.80
10 A comparison of laparoscopic and open Nissen fundoplication and gastrostomy placement in the neonatal intensive care unit population. J Pediatr Surg 2010 0.79
11 Hepatocyte growth factor and omega-3-enriched feeds have a synergistic effect on mucosal mass in an animal model of inflammatory bowel disease. J Pediatr Surg 2012 0.78
12 The effect of hepatocyte growth factor on gene transcription during intestinal adaptation. J Pediatr Surg 2011 0.77
13 Hepatocyte growth factor ameliorates inflammatory bowel disease in a rat model. J Gastrointest Surg 2003 0.77
14 Interleukin-11 enhances intestinal absorptive function after ischemia-reperfusion injury. J Pediatr Surg 2002 0.77
15 Dose variation of hepatocyte growth factor and its effects on an animal model of TPN-induced liver injury. J Surg Res 2010 0.77
16 Glucagonlike peptide-2 analogue: a possible new approach in the management of inflammatory bowel disease. J Pediatr Surg 2004 0.77
17 Chronology of the effect of massive small bowel resection and hepatocyte growth factor (HGF) on intestinal adaptation. J Surg Res 2011 0.77
18 Gene alterations and intestinal mucosal changes following growth factor and omega-3 exposure in a rat model of inflammatory bowel disease. J Pediatr Surg 2013 0.77
19 Growth factor manipulation of intestinal angiogenesis: a possible new paradigm in the management of inflammatory bowel disease. J Surg Res 2009 0.75
20 Successful endovascular repair of exsanguinating penetrating carotid artery injury in two pediatric patients. Pediatr Surg Int 2015 0.75
21 Hepatocyte growth factor increases glucagon immunoreactivity in jejunal cells during intestinal adaptation. J Pediatr Surg 2006 0.75
22 Proteasome gene upregulation: a possible mechanism for intestinal adaptation. J Pediatr Surg 2005 0.75
23 Prophylactic antibiotics do not decrease the incidence of wound infections after laparoscopic pyloromyotomy. J Pediatr Surg 2011 0.75
24 Transfection of the sodium/glucose cotransporter into colon mucosa: a novel treatment for short bowel syndrome. J Pediatr Surg 2002 0.75
25 Growth factor modulation of hepatic inflammation: a novel approach to the management of total parenteral nutrition-associated liver disease. J Pediatr Surg 2010 0.75
26 Study of an ovarian sclerosing stromal tumor presenting as vaginal bleeding in a 7-month-old. Pediatr Dev Pathol 2007 0.75
27 Terminal ileal atresia, total colonic aganglionosis, and thrombophilia. Pediatr Dev Pathol 2009 0.75
28 A possible mechanism for prevention of intestinal programmed cell death after ischemia-reperfusion injury by hepatocyte growth factor pretreatment. J Pediatr Surg 2002 0.75
29 A rare cause of vaginal bleeding in a 7-month-old female infant. J Pediatr Surg 2008 0.75